National Cancer Institute (NCI) to further study combining the molecular analysis of glioblastoma with MRI.
The center will be based at Mayo Clinic in Arizona with co-principal investigator Peter Canoll, M.D., Ph.D., Columbia University, and involves collaboration among multiple institutions, including Arizona State University, Columbia University, City of Hope, Inova, Mayo Clinic Rochester, MD Anderson and Washington University.Continue reading
The IRA requires CMS to establish a new Part D manufacturer discount program beginning on January 1, 2025 as part of the redesign of Part D.Continue reading
Arizona was awarded 6 new GME slots out of the 200 total newly announced awardsContinue reading
College of Medicine – Tucson researchers used stem cell technology to improve research models for Parkinson’s disease.
Arizona Bioindustry Association Selects CND as a 2023 Fast Lane Honoree for Outstanding AchievementsContinue reading
Governor Katie Hobbs releases official proclamation supporting the recognition of “Cancer Caregivers Awareness Week” across Arizona.Continue reading
TAMPA, Fla. – CancerX, co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe) alongside the Office of the National Coordinator for Health Information Technology and the Office of the Assistant Secretary for Health announced the launch of the CancerX Startup Accelerator today at the Future of Cancer Care Summit in Tampa, Fla. It is the first-ever national cancer innovation accelerator initiative with public support from the White House.
November 9, 2023 – An Arizona State University startup is one step closer to developing tiny, noninvasive wearable devices to measure real-time glucose levels in sweat after winning Skysong Innovations’ 2023 Startup Challenge. Four finalists received seed funding.Continue reading
College of Medicine – Tucson researchers will lead a clinical trial examining one hormone’s ability to reduce impairments following traumatic brain injury.Continue reading
PHOENIX, NOVEMBER 7, 2023 — City of Hope®, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of Alan H. Bryce, M.D., as the chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope. He joins City of Hope from Mayo Clinic, where he served as chair of the Division of Hematology and Medical Oncology in the Department of Internal Medicine at Mayo Clinic in Arizona and director of Mayo Clinic Comprehensive Cancer Center in Arizona. Continue reading